Provided is a pharmaceutical composition that includes one or more inactivatedMycobacterium spp., which are preferably inactivated using gamma irradiation,and which is than formulated for mucosal or pulmonary delivery to a subject. Thepharmaceutical compositions are useful for preventing or treating mycobacterium-associatedinfections in a subject, including a human subject.